Skip to NavigationSkip to content


Japanese company is latest to disinvest in hostile German environment
Proposals to scrap PPRS and introduce value-based system
Move opens door for ReNeuron to US biotech and stem cell therapy markets
Lybrel offers women freedom from monthly bleeding
Product roundup in MS, cancer, epilepsy, HIV and obesity
Second round of redundancies in effort to save company $900m
New powers for police take effect but ABPI warns against complacency
But revenues boosted by 12% growth in Seretide/Advair
But rules out further structural reorganisation and political independence
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches